Did you ever hear of bonus pills when buying Biaxin at your local pharmacy?

FAST H. PYLORI REGIMEN
Rabeprazole sodium (Aciphex) is now approved in combination with antibiotics to treat Helicobacter pylori infection in 7 days. Current treatments for H. pylori infection take 10-14 days.
In combination with amoxicillin and clarithromycin (Biaxin) as a threedrug regimen, rabeprazole is indicated for the treatment of H. pylori infection and duodenal ulcer disease (active or history within the last 5 years) to eradicate H. pylor…

Biaxin XL Filmtab (clarithromycin extended-release tablets)
Biaxin Granules (clarithromycin for oral suspension, USP)
WARNINGS
Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including Biaxin, and may range in severity from mild diarrhea to fatal c…

Teva Pharmaceutical Industries Ltd. was hit with a temporary restraining order by the U.S. District Court for the District of Northern Illinois that prevented the company from introducing its clarithromycin extended-release tablets (500 m…

Abbott loses bid to halt generic LIBERTYVILLE TOWNSHIP - Abbott Laboratories lost its challenge to a generic-drug company’s proposed immediate-release version of the antibiotic drug Biaxin. Canada’s Supreme Court Thursday dismissed without explanation the company’s claim that Ra…

The first antibiotic treatment for eradicating Helicobacter pylori, the bacteria associated with active duodenal ulcers, has been approved by FDA.
The treatment involves taking two previously approved drugs: Biaxin (clarithromycin) and Prilosec (omeprazole). It was approved April 18.
Biaxin, manufactured by Abbott Laboratories, is an antibiotic for various mild to moderate infections. Prilosec, manufactured by Astra Merck, is a proton pump inhibitor that helps heal u…

Abbott Laboratories, Abbott Park, Ill., in late April sent cases of hospital, pharmaceutical and nutritional products valued at $2.1 million to AmeriCares, a not-for-profit humanitarian aid organization, to aid victims of the war in Iraq. Anothe…

Big Foot reports smaller profit LONG GROVE - Big Foot Financial Corp. announced first-quarter earnings ended Sept. 30 of $157,000, or 10 cents per share, down from $181,000, or 9 cents per share the same quarter a year ago. Net interest income declined to $1.5 million from $1.6 million in 1999.

Related Results

Biaxin FilmtabTeva Provides Generic Biaxin XL UpdateFDA OKs Abbott…

Abbott Laboratories has received FDA approval for a community acquired pneumonia (CAP) indication for Biaxin XL (clarithromycin extended-release tablets). The product is a once-daily version of Biaxin and is indicated for treating mild to moderate CAP.

Related Results

Biaxin FilmtabTeva Provides Generic Biaxin XL UpdateFDA OKs Abbott's seven-day Biaxin treatmentAndrx Receives Final Approval fo…

Biaxin XL (clarithromycin extended-release tablets) has a new 7-day indication for the treatment of mild to moderate community-acquired pneumonia. The once-daily formulation is indicated for the treatment of community-acquired pneumonia caused by Haemophilus influenzae, H. parainfluenzae, Morax…

The Centers for Disease Control and Prevention (CDC) has released guidelines on antimicrobial agents for the treatment and postexposure prophylaxis of pertussis. The full report was published in the December 9, 2005, issue of Morbidity…